525 related articles for article (PubMed ID: 22632973)
1. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
[TBL] [Abstract][Full Text] [Related]
2. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance.
Han F; Li CF; Cai Z; Zhang X; Jin G; Zhang WN; Xu C; Wang CY; Morrow J; Zhang S; Xu D; Wang G; Lin HK
Nat Commun; 2018 Nov; 9(1):4728. PubMed ID: 30413706
[TBL] [Abstract][Full Text] [Related]
3. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
[TBL] [Abstract][Full Text] [Related]
4. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
[TBL] [Abstract][Full Text] [Related]
5. Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis.
Yang ZY; Zhao YW; Xue JR; Guo R; Zhao Z; Liu HD; Ren ZG; Shi M
World J Gastroenterol; 2023 Dec; 29(45):5974-5987. PubMed ID: 38130998
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer.
He YF; Liu YP; Liao JZ; Gan Y; Li X; Wang RR; Wang F; Zhou J; Zhou L
Am J Chin Med; 2024; 52(3):865-884. PubMed ID: 38790085
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
Lu Y; Zi X; Pollak M
Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
[TBL] [Abstract][Full Text] [Related]
8. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
Oncogene; 2020 Nov; 39(47):7034-7050. PubMed ID: 32989258
[TBL] [Abstract][Full Text] [Related]
9. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of decidual SKP2 is associated with human recurrent miscarriage.
Lv S; Liu M; Xu L; Zhang C
Reprod Biol Endocrinol; 2021 Jun; 19(1):88. PubMed ID: 34116705
[TBL] [Abstract][Full Text] [Related]
11. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
[TBL] [Abstract][Full Text] [Related]
12. Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing Cdh1-Mediated Skp2 Ubiquitination.
Gan Y; Zhou L; Wang R; Zhang Y; Li X; Han S; Rong P; Wang W; Li W
Am J Chin Med; 2023; 51(3):723-740. PubMed ID: 36866798
[TBL] [Abstract][Full Text] [Related]
13. Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis.
Xu D; Li CF; Zhang X; Gong Z; Chan CH; Lee SW; Jin G; Rezaeian AH; Han F; Wang J; Yang WL; Feng ZZ; Chen W; Wu CY; Wang YJ; Chow LP; Zhu XF; Zeng YX; Lin HK
Nat Commun; 2015 Mar; 6():6641. PubMed ID: 25818643
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.
Chan CH; Morrow JK; Li CF; Gao Y; Jin G; Moten A; Stagg LJ; Ladbury JE; Cai Z; Xu D; Logothetis CJ; Hung MC; Zhang S; Lin HK
Cell; 2013 Aug; 154(3):556-68. PubMed ID: 23911321
[TBL] [Abstract][Full Text] [Related]
16. The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KKC; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 Nov; 151(4):913-914. PubMed ID: 30360292
[No Abstract] [Full Text] [Related]
17. Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1.
Wu J; Zhang X; Zhang L; Wu CY; Rezaeian AH; Chan CH; Li JM; Wang J; Gao Y; Han F; Jeong YS; Yuan X; Khanna KK; Jin J; Zeng YX; Lin HK
Mol Cell; 2012 May; 46(3):351-61. PubMed ID: 22464731
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.
Lin HK; Wang G; Chen Z; Teruya-Feldstein J; Liu Y; Chan CH; Yang WL; Erdjument-Bromage H; Nakayama KI; Nimer S; Tempst P; Pandolfi PP
Nat Cell Biol; 2009 Apr; 11(4):420-32. PubMed ID: 19270694
[TBL] [Abstract][Full Text] [Related]
19. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.
Gijsen M; King P; Perera T; Parker PJ; Harris AL; Larijani B; Kong A
PLoS Biol; 2010 Dec; 8(12):e1000563. PubMed ID: 21203579
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Skp2 expression and activity and its role in cancer progression.
Chan CH; Lee SW; Wang J; Lin HK
ScientificWorldJournal; 2010 Jun; 10():1001-15. PubMed ID: 20526532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
